Leerink Partners ER
Anyone have thoughts on how leerinks ER will do after the break from SVB? Not saying SVB helped with ER, but will bonuses be significantly cut across the firm? Does this effect how they fair in HC ER rankings in the short to medium term?
Based on the most helpful WSO content, it's hard to predict exactly how Leerink Partners' Equity Research (ER) will perform after the break from SVB. The impact on bonuses and their standing in Healthcare (HC) ER rankings could depend on a variety of factors, including the firm's financial health, the performance of their ER team, and market conditions.
However, it's worth noting that Leerink Partners has a strong reputation in the healthcare sector, which could serve them well in their ER rankings. As for bonuses, these can fluctuate based on a number of factors, including the overall performance of the firm and the specific performance of the ER department.
Remember, these are just educated guesses. The actual outcomes could be different and it's always a good idea to keep an eye on industry news and updates for the most accurate information.
Sources: Is SVB Leerink Becoming an EB?, SVB Going Under?, Return of Leerink Partners, SVB Leerink
.
Error autem a quos dicta qui voluptates explicabo. Error amet aut dolor non officiis. Dolores assumenda rerum vitae sit. Eos sint non quisquam. Eaque minus dolorem est sit cumque quia mollitia.
Dolores magnam nihil quia blanditiis. Sapiente eligendi omnis quo iste cumque. Ab nemo excepturi quos est dolorum iure.
In excepturi nemo sed repellendus dolorem dolores veniam. Ipsa magnam tempore dolor. Aliquam culpa qui iste rerum doloremque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...